Danielle Chun

Takeda Pharmaceutical Company Limited

Poster(s):

• (B-222) Comparison of time-to-next treatment and time-to-event endpoints using real-world data in checkpoint inhibitor-treated patients with advanced non-small cell lung cancer
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET

• (B-168) Real-world treatment patterns and clinical outcomes in patients with metastatic castration-resistant prostate cancer (mCRPC) who received a third line treatment
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET